Home › Drug Codes › J Codes › J1596 · GLYCOPYRROLATE INJECTION
Updated October 1st, 2026

GLYCOPYRROLATE INJECTION J Code: J1596

Injection, glycopyrrolate, 0.1 mg

Login to unlock all benchmarks
Medicare Payment Limit ?
$0.33
/ HCPCS billing unit
APC Payment Limit ?
Not published
CMS publishes none for Q4 2026
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
124
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, glycopyrrolate, 0.1 mg
HCPCS Added Date January 1, 2024
Manufacturer Multiple Manufacturers
Route of Administration Intramuscular, Intravenous
Generic Status Multi-Source; Generic
Dosage Type Single-Dose, Multi-Dose
Dosage Form Injection | Injection, Solution | Not Available | Solution

About GLYCOPYRROLATE INJECTION

Glycopyrrolate Injection is a medication aligned to the HCPCS J Code: J1596 for billing, pricing, and reimbursement purposes in the United States. This Respiratory medication is administered via the intramuscular or intravenous routes and manufactured by multiple companies.

According to CMS Drug Use Information: Drug uses not available

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 124 NDCs — log in for the full crosswalk.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00143-9584-10 Glycopyrrolate Hikma Pharmaceuticals USA Inc. 400 4 MG / 20 ML
00517-4601-25 Glycopyrrolate American Regent, Inc. 50 0.2 MG / 1 ML
00781-3825-96 Glycopyrrolate Sandoz Inc 50 0.2 MG / 1 ML
25021-0796-01 Glycopyrrolate Sagent Pharmaceuticals 50 0.2 MG / 1 ML
50090-4513-00 Glycopyrrolate Injection A-S Medication Solutions 2 0.2 MG
•••••-••••-•• Log in to view GLYCOPYRROLATE INJECTION
GLYCOPYRROLATE INJECTION
GLYCOPYRROLATE INJECTION
Login to view 119 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

GLYCOPYRROLATE INJECTION Pricing & Reimbursement

J1596 Private Payer Reimbursement
$0.70 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q4 2026

Glycopyrrolate 505(b)(2) Information:

HCPCS Code Manufacturer Active Ingredient HCPCS Description
J1596 Generic Code (Multiple Manufacturers) Glycopyrrolate Injection, glycopyrrolate, 0.1 mg
J1597 Exela Pharma Sciences Glycopyrrolate Injection, glycopyrrolate (glyrx-pf), 0.1 mg
J1598 Fresenius Kabi Glycopyrrolate Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg

GLYCOPYRROLATE INJECTION CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96372 Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular
Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

GLYCOPYRROLATE INJECTION Medically Unlikely Edits (MUE)

The most billing units of J1596 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 0.1 mg.

Practitioner Office & Hospital Outpatient
18 units / day
= 1.8 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

GLYCOPYRROLATE INJECTION Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Anesthesia Drug-induced or vagal reflex-associated arrhythmias (e.g., bradycardia) Drug-induced or vagal reflex-associated arrhythmias (intraoperative) Intraoperative Arrhythmia Intraoperative Arrhythmia Management Intraoperative Medication Intraoperative Medication (arrhythmia counteraction) Intraoperative arrhythmia (anesthesia) Intraoperative arrhythmia (counteracting vagal/drug-induced reflexes) Intraoperative arrhythmia management Intraoperative arrhythmia management (anesthesia) Intraoperative arrhythmias Intraoperative arrhythmias (drug-induced or vagal reflex) Intraoperative arrhythmias (vagal/drug-induced) Intraoperative drug-induced or vagal reflex-associated arrhythmias Intraoperative medication (counteracting drug-induced or vagal arrhythmias) Peptic Ulcer Peptic ulcer Preanesthetic Preanesthetic Medication Preanesthetic medication Preanesthetic medication (reduction of secretions and cardiac vagal reflexes) Preanesthetic medication (reduction of secretions and vagal reflexes) Preoperative antimuscarinic (anesthesia) Preoperative antimuscarinic (preanesthetic medication) Reversal of Neuromuscular Blockade Reversal of neuromuscular blockade Reversal of neuromuscular blockade (anesthesia)
Drug Class
Anticholinergic [EPC]Cholinergic Antagonists [MoA]Cholinergic Muscarinic Antagonist [EPC]Cholinergic Muscarinic Antagonists [MoA]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.
Access Full Report →

Frequently Asked Questions

Is there an available Glycopyrrolate Injection billing and coding guide?
We have not yet identified a manufacturer source of Glycopyrrolate Injection billing and coding information.
Are there any available Glycopyrrolate Injection patient assistance programs?
Our team did not identify a source for Glycopyrrolate Injection patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Glycopyrrolate Injection prescribing information?
GLYCOPYRROLATE INJECTION prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date. Visit Here →
Where can I find Glycopyrrolate Injection side effect information?
Our team has not yet identified a source of side effects information for GLYCOPYRROLATE INJECTION. Please check back in a few weeks.
Does billing GLYCOPYRROLATE INJECTION require JZ/JW wastage modifiers?
CMS does not include GLYCOPYRROLATE INJECTION (J1596) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J1596. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.

Related Drug Codes

Explore billing, coding, and pricing for drugs related to GLYCOPYRROLATE INJECTION.

J1597Glyrx-PfInjection, glycopyrrolate (glyrx-pf), 0.1 mgExela Pharma SciencesAdded July 1, 2024J1598GlycopyrrolateInjection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mgFresenius KabiAdded July 1, 2024J1308FAMOTIDINE PREMIXEDInjection, famotidine, 0.25 mgMultiple ManufacturersAdded April 1, 2025J2060ATIVANInjection, lorazepam, 2 mgMultiple ManufacturersAdded January 1, 1982J7644IPRATROPIUM BROMIDEIpratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligramMultiple ManufacturersAdded January 1, 2000J7677YupelriRevefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgramViatrisAdded July 1, 2019J0461ATROPINE SULFATEInjection, atropine sulfate, 0.01 mgMultiple ManufacturersAdded January 1, 2010J0462ATROPINE SULFATEInjection, atropine sulfate, not therapeutically equivalent to j0461, 0.01 mgMultiple ManufacturersAdded October 1, 2025J0463Atropine SulfateInjection, atropine sulfate (fresenius and therapeutically equivalent), 0.01 mgMultiple ManufacturersAdded April 1, 2026J0500DICYCLOMINE HCIInjection, dicyclomine hcl, up to 20 mgMultiple ManufacturersAdded January 1, 1986